Concepedia

Author

Jennifer Visich

HistoGenetics (United States)

Also Known As

J Visich, J. Visich, J.E. VISICH, Jennifer E Visich, Jennifer E. Visich, Jennifer Visich

42

Publications

1.7K

Citations

21

H-Index

45

Concepts

All Affiliations

HistoGenetics (United States)Roche (Switzerland)Roche (United Kingdom)GenentechUnity Biotechnology (United States)
JV

About

Jennifer Visich is an author at HistoGenetics (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

15

676

2

Health Sciences

1

1

77

3

Allergy

1

1

12

4

Allergy Medicine

1

1

12

5

Diabetes

1

1

37

Jennifer Visich

×

23

Publications

1.5K

Citations

21

H-Index

YearCitations

Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD

Robert L. Avery, Alessandro Castellarin, Nathan Steinle,

British Journal of Ophthalmology

2014

362

A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis

Paul Rutgeerts, Richard N. Fedorak, Daan W. Hommes,

Gut

2012

150

Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration

Yanan Zheng, Devin B. Tesar, Lisa J. Benincosa,

mAbs

2012

135

Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency

Amy E. Lovejoy, Tom C. Reynolds, Jennifer Visich,

Blood

2006

117

Population Pharmacokinetics of Rituximab in Patients With Chronic Lymphocytic Leukemia

Jing Li, Jianguo Zhi, Michael Wenger,

The Journal of Clinical Pharmacology

2012

77

Population pharmacokinetic and exposure–response analysis for trastuzumab administered using a subcutaneous “manual syringe” injection or intravenously in women with HER2-positive early breast cancer

Angelica Quartino, Carina Hillenbach, Jing Li,

Cancer Chemotherapy and Pharmacology

2015

72

Safety, pharmacokinetics and pharmacodynamics of atacicept in healthy volunteers

Alain Munafo, Anthony Priestley, Ivan Nestorov,

European Journal of Clinical Pharmacology

2007

60

Population pharmacokinetic and covariate analysis of pertuzumab, a HER2-targeted monoclonal antibody, and evaluation of a fixed, non-weight-based dose in patients with a variety of solid tumors

Amit Garg, Angelica Quartino, Jing Li,

Cancer Chemotherapy and Pharmacology

2014

59

Pharmacokinetics and Biological Activity of Atacicept in Patients With Rheumatoid Arthritis

Ivan Nestorov, Alain Munafo, Orestis Papasouliotis,

The Journal of Clinical Pharmacology

2008

50

Nonclinical Safety, Pharmacokinetics, and Pharmacodynamics of Atacicept

Michela Carbonatto, Ping Yu, Mauro Bertolino,

Toxicological Sciences

2008

48

Page 1